Novel Anti-FOLR1 Antibody–Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells

Antibody–drug conjugates (ADCs), which are currently being developed, may become promising cancer therapeutics. Folate receptor α (FOLR1), a glycosylphosphatidylinositol-anchored membrane protein, is an attractive target of ADCs, as it is largely absent from normal tissues but is overexpressed in ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunaga, Yuki, Yamaoka, Toshimitsu, Ohba, Motoi, Miura, Sakiko, Masuda, Hiroko, Sangai, Takafumi, Takimoto, Masafumi, Nakamura, Seigo, Tsurutani, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930947/
https://www.ncbi.nlm.nih.gov/pubmed/33535554
http://dx.doi.org/10.3390/antib10010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930947/
https://www.ncbi.nlm.nih.gov/pubmed/33535554
http://dx.doi.org/10.3390/antib10010006

Ejemplares similares